On its website Monday the FDA stated “The U.S. Court of Appeals for the D.C. Circuit, in Sottera, Inc. v. Food & Drug Administration, 627 F.3d 891 (D.C. Cir. 2010), recently issued a decision with regard to e-cigarettes and other products “made or derived from tobacco” and the jurisdictional line that should be drawn between “tobacco products” and “drugs,” “devices,”
inLife States “Birth of an Industry”
inLife was one of the very first companies to market the e-cig and first brought the e-cig to market in early 2008. inLife’s structure as a network marketing company made inLife one of the fastest growing network marketing companies in U.S. history. Said inLife Founder Craig Youngblood “This is truly the birth of an industry. Since 2008 we have tens of thousands of people who have been using our e-cig and the testimonies I hear are just so heartwarming. We have obviously been following the litigation closely and are thrilled that the e-cig is now regulated as a tobacco product as we agree that the industry should be overseen by the FDA under the Tobacco Control Act”. inLife also is the Co-Founding Company of the Tobacco Vapor Electronic Cigarette Association (TVECA) which is the entity established to work with the e-cig industry to provide to the public, the media and legislative bodies solely the Facts, Science and Compliance issues of the industry and work with the FDA in overseeing that e-cig companies are in compliance with all local, state and federal tobacco regulations.
About inLife, LLC
Founded in 2007, inLife has been very successful in bringing to market products that have efficacies that are soundly based on scientific research. inLife products are now available in the U.S. as well as the U.K, Canada, Singapore and Spain. For more information on the inLife Electronic Cigarette and the company, please review www.myinlife.com. For further details on this release and the inLIfe e-cig, journalists may contact Thomas Kiklas directly at 949-648-2525.
# # #
Founded in 2007, inLife has been very successful in bringing to market products that have efficacies that are soundly based on scientific research. For further details on inForce, journalists may contact Thomas Kiklas directly at 949-648-2525.